In this discussion, we will refer to DSM-5 TR to present the following topics:
* Prevalence
* 11 diagnostic criteria
* When are the criteria not met?
* Severity assessment
* Notes for specifiers
* ICD-10 codes based on the current severity/remission
* Diagnostic markers
* Further reading
References:
dsm-5-dx-oud-8-28-2017.pdf
https://www.asam.org/docs/default-source/education-docs/dsm-5-dx-oud-8-28-2017.pdf
Psychiatry.org - DSM
https://www.psychiatry.org/psychiatrists/practice/dsm
* Understand the prevalence of Opioid Use Disorder.
* Familiarize with the 11 diagnostic criteria for Opioid Use Disorder.
* Recognize situations when the diagnostic criteria are not met.
* Learn about severity assessment in Opioid Use Disorder.
* Understand the notes for specifiers in the diagnosis of Opioid Use Disorder.
* Identify the ICD-10 codes associated with the current severity/remission of Opioid Use Disorder.
* Recognize diagnostic markers related to Opioid Use Disorder.
* Explore additional resources for further reading on Opioid Use Disorder.
Faculty
In addition to the presenter, following authors may have helped with the content writing, review,
or approval:
CME, CE, CEU and Other Credit Types:
ACCME Accreditation Statement
The DrBeen Corp is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to
provide continuing medical education for physicians.
AMA Credit Designation Statement
The DrBeen Corp designates this enduring material for a maximum of 0.75 AMA PRA Category 1
Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the
activity.
Disclosure Information
In accordance with the disclosure policies of DrBeen Corp and the ACCME (Accreditation Council for
Continuing Medical Education), we are committed to upholding principles of balance, independence,
objectivity, and scientific rigor in all of our Continuing Medical Education (CME) and Continuing
Education (CE) activities. These policies include the careful management and mitigation of any relevant
financial relationships with organizations that are not eligible.
All members of the Activity Planning Committee and presenters have disclosed their relevant financial
relationships. The DrBeen Corp CE Committee has thoroughly reviewed these disclosures and determined
that these relationships are not deemed inappropriate in the context of their respective presentations.
Additionally, they are found to be consistent with the educational objectives and the integrity of the
activity.
Faculty |
Disclosures |
Dr. Mobeen Syed |
Author declares no conflict of interest. |
Write A New Comment
1 Comments
fmk94152@*.com
Mar 18 2024, 11:19 am
opioid